All In Biotech

Drug Trial Radar · NCT03878446

A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

A Dose-finding Trial Evaluating the Effect and Safety of Once-weekly Treatment of Somapacitan Compared to Daily Norditropin® in Children With Short Stature Born Small for Gestational Age With no Catch-up Growth by 2 Years of Age or Older

Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

62

Actual

Start

Jul 4, 2019

Primary completion

May 5, 2021

Study completion Dec 23, 2026

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Mar 18, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 11 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study compares 2 medicines used for the treatment of children who are born small and who stayed small: somapacitan given once a week (a new medicine) and Norditropin® given once a day (the medicine doctors can already prescribe). Participants will either get somapacitan or Norditropin® - which treatment is decided by chance. Both participants and the study doctor will know which treatment the participants get. The study will last for 5 years. Participants will take either an injection once every week or once every day.

Conditions

  • Short Stature Children Born Small for Gestational Age (SGA)

Interventions

  • SomapacitanDrug

    Somapacitan injected under the skin once a week.

  • Norditropin®Drug

    Norditropin® injected under the skin once a day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Height VelocityTime frame: Baseline (week 0); week 26

Locations

95 sites in 23 countries. Site status is shown where the registry gives one.

  • Univ of AL at Birmingham_BRM

    Birmingham, Alabama

  • Children's Hosp Of Orange

    Orange, California

  • St. Luke's Children's Endo

    Boise, Idaho

  • Univ of Minnesota M.C.H.

    Minneapolis, Minnesota

  • Children's Minnesota

    Saint Paul, Minnesota

  • Goryeb Children's Hospital

    Morristown, New Jersey

  • Rutgers-Rwjms

    New Brunswick, New Jersey

  • NYU Langone Hospital-LI

    Garden City, New York

  • NYU Langone Hospital-LI

    Mineola, New York

  • Icahn Sch of Med-Mt Sinai Hosp

    New York, New York

  • CCHMC_Cinc

    Cincinnati, Ohio

  • Univ Oklahoma Sci Ctr OK City

    Oklahoma City, Oklahoma

  • Cook Children's Hospital-Hematology-Oncology

    Fort Worth, Texas

  • MultiCare Inst for Res & Innov

    Tacoma, Washington

  • CHU Bab El Oued Pediatrics Dept

    Algiers, Algeria

  • Endo and Diab Dept El Oued

    Algiers, Algeria

  • endocrino-diabetology department, Hospital IBN BADIS.

    Constantine, Algeria

  • Med. Univ. Graz -Klinische Abteilung f. Allgemeine Pädiatrie

    Graz, Austria

  • LKH Salzburg- Univ. Klinik f. Kinder- und Jugendheilkunde

    Salzburg, Austria

  • LKH St. Poelten, Kinder-und Jugendheilkunde

    Sankt Pölten, Austria

  • Salzkammergut-Klinikum Vöcklabruck

    Vöcklabruck, Austria

  • Kepler Universitätsklinikum GmbH - Med Campus IV (vorm.LFKK)

    Linz, Upper Austria, Austria

  • Stollery Children's Hospital

    Edmonton, Alberta, Canada

  • Rigshospitalet Klinik for Vækst og Reproduktion Afsnit 5064

    Copenhagen Ø, Denmark

  • Tallinn Children's Hospital

    Tallinn, Estonia

  • Tartu University Hospital Children's Clinic

    Tartu, Estonia

  • Centre Hospitalier Universitaire D'Angers-2

    Angers, France

  • AP-HP-HOPITAL DE BICETRE_Service d'Endocrinologie pédiatrique

    Le Kremlin-Bicêtre, France

  • Assistance Publique Hopitaux de Marseille-Hopital de La Timone-2

    Marseille, France

  • Hopital de La Timone

    Marseille Cédex 05, France

  • Ap-Hp-Hopital Necker

    Paris, France

  • Hôpital Necker

    Paris, France

  • HOPITAL DES ENFANTS-HOPITAL PAULE DE VIGUIER - Pharmacie

    Toulouse, France

  • Észak-Közép-budai Centrum, Szent János Kórház és Szakrendelő

    Budapest, Hungary

  • Szegedi Tudományegyetem Gyermekgyógyászati Klinika

    Szeged, Hungary

  • Amrita Institute Of Medical Sciences & Research Centre

    Kochi, Kerala, India

  • Jehangir Clinical Development Centre

    Pune, Maharashtra, India

  • All India Institute of Medical Sciences

    New Dehli, New Delhi, India

  • CHI Crumlin Dept of Endocrinology

    Dublin, Ireland

  • Rambam MC - Department of Pediatrics A

    Haifa, Israel

Showing 40 of 95 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.